- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Parelsnoer Institute the Netherlands
Total 386 results
-
The Netherlands Cancer InstituteNot yet recruitingDrug Adherence Marker
-
The Netherlands Cancer InstituteRecruiting
-
The Netherlands Cancer InstituteRecruitingBreast Cancer Patients Undergoing Mastectomy With Immediate ReconstructionNetherlands
-
The Netherlands Cancer InstituteRecruiting
-
The Netherlands Cancer InstituteRecruiting
-
The Netherlands Cancer InstituteRecruitingCutaneous Squamous Cell CarcinomaNetherlands
-
The Netherlands Cancer InstituteRecruitingLocally Advanced, Squamous Cell Carcinoma of the VulvaNetherlands
-
The Netherlands Cancer InstituteRecruitingMetastatic Squamous Cell Carcinoma of the VulvaNetherlands
-
The Netherlands Cancer InstituteRecruitingOvarian CancerNetherlands, United States, France, Denmark, Italy, Sweden, Ireland
-
The Netherlands Cancer InstituteNot yet recruitingTesticular Germ Cell Tumor
-
The Netherlands Cancer InstituteCompletedCarcinoma, Squamous Cell of Head and NeckNetherlands
-
The Netherlands Cancer InstituteCompletedHead and Neck Neoplasms | ImmunotherapyNetherlands
-
The Netherlands Cancer InstituteCompletedProstate Cancer | Solid Tumor, AdultNetherlands
-
The Netherlands Cancer InstituteCompletedColorectal Neoplasms | Testicular CancerNetherlands
-
The Netherlands Cancer InstituteCompletedHead and Neck Cancer | Penile CancerNetherlands
-
The Netherlands Cancer InstituteActive, not recruitingBreast CancerNetherlands
-
The Netherlands Cancer InstituteCompletedMetastasis | Prostate Cancer MetastaticNetherlands
-
The Netherlands Cancer InstituteUnknownMetastatic Gastric Cancer | Adenocarcinoma of the Gastro-oesophageal JunctionNetherlands
-
The Netherlands Cancer InstituteUnknownProstate CancerNetherlands
-
The Netherlands Cancer InstituteTerminatedHead and Neck NeoplasmsNetherlands
-
The Netherlands Cancer InstituteCompletedLung Cancer | Metastatic Lung CancerNetherlands, United States, Canada, Germany
-
The Netherlands Cancer InstituteCompleted
-
The Netherlands Cancer InstituteCompletedBreast Cancer | Ovarian Cancer | Advanced CancerNetherlands
-
The Netherlands Cancer InstituteCompleted
-
The Netherlands Cancer InstituteUnknownStage IV Skin Melanoma | Eye; MelanomaNetherlands
-
The Netherlands Cancer InstituteCompletedOvarian CancerNetherlands
-
The Netherlands Cancer InstituteUnknown
-
The Netherlands Cancer InstituteCompleted
-
The Netherlands Cancer InstituteCompleted
-
The Netherlands Cancer InstituteUnknownDrug Safety BiomarkersNetherlands
-
The Netherlands Cancer InstituteCompletedCocaine AddictionNetherlands
-
The Netherlands Cancer InstituteUnknown
-
The Netherlands Cancer InstituteUnknownMeningeal CarcinomatosisNetherlands
-
The Netherlands Cancer InstituteBayerCompletedBone Metastases | Prostate Cancer MetastaticNetherlands
-
The Netherlands Cancer InstituteAstraZenecaSuspendedBreast CancerNetherlands
-
The Netherlands Cancer InstituteAstraZenecaCompleted
-
The Netherlands Cancer InstitutePfizerUnknown
-
The Netherlands Cancer InstitutePfizerCompletedMalignant Pleural MesotheliomaNetherlands
-
The Netherlands Cancer InstitutePfizerUnknownMalignant Solid TumourNetherlands
-
The Netherlands Cancer InstituteAstraZenecaRecruitingOsimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. (OSIRIS)Non-small-cell Lung CarcinomaNetherlands
-
The Netherlands Cancer Institute4SCActive, not recruiting
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingHead and Neck Neoplasms | Carcinoma, Squamous Cell | Laryngeal Cancer Stage II | Laryngeal Cancer Stage IIINetherlands
-
The Netherlands Cancer InstituteAmgenActive, not recruitingMelanoma Stage IV | Melanoma Stage IIINetherlands
-
The Netherlands Cancer InstituteBayerCompletedBone Metastases | Prostate Cancer MetastaticNetherlands
-
The Netherlands Cancer InstituteUNICANCERActive, not recruiting
-
Netherlands Heart FoundationThe Interuniversity Cardiology Institute of the NetherlandsCompleted
-
The Netherlands Cancer InstitutePfizerRecruitingRenal Cell CarcinomaNetherlands
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingUrothelial CarcinomaNetherlands
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingBreast CancerNetherlands
-
The Netherlands Cancer InstituteAstraZenecaUnknown